Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Other Infectious Diseases × Meropenem × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Febrile Neutropenia 5 Neoplasms 3 Urinary Bladder Neoplasms 1 Sepsis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Other Infectious Diseases 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 Fever 1 Emergencies 1

Interventions

ceftolozane 1 Tazobactam 1 Piperacillin, Tazobactam Drug Combination 1 Meropenem 1 Cefepime 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03485950 2022-03-15

Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam

M.D. Anderson Cancer Center

Phase 2 Completed

100 enrolled 33 charts

Other Infectious Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡